Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
| Autor: | Lawrence Scholl, Puja Seth, Rose A. Rudd, Felicita David |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Health (social science) Adolescent Epidemiology Health Toxicology and Mutagenesis Drug overdose Heroin Young Adult 03 medical and health sciences 0302 clinical medicine Health Information Management Naloxone medicine Humans 030212 general & internal medicine Child Aged Harm reduction business.industry Infant Newborn Infant Opioid overdose Opioid use disorder General Medicine Middle Aged medicine.disease United States Analgesics Opioid Opioid Child Preschool Emergency medicine Female Medical emergency Drug Overdose business 030217 neurology & neurosurgery medicine.drug Methadone |
| Zdroj: | MMWR. Morbidity and Mortality Weekly Report. 65:1445-1452 |
| ISSN: | 1545-861X 0149-2195 |
| Popis: | The U.S. opioid epidemic is continuing, and drug overdose deaths nearly tripled during 1999-2014. Among 47,055 drug overdose deaths that occurred in 2014 in the United States, 28,647 (60.9%) involved an opioid (1). Illicit opioids are contributing to the increase in opioid overdose deaths (2,3). In an effort to target prevention strategies to address the rapidly changing epidemic, CDC examined overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014-2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone).* Rates were stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. During 2015, drug overdoses accounted for 52,404 U.S. deaths, including 33,091 (63.1%) that involved an opioid. There has been progress in preventing methadone deaths, and death rates declined by 9.1%. However, rates of deaths involving other opioids, specifically heroin and synthetic opioids other than methadone (likely driven primarily by illicitly manufactured fentanyl) (2,3), increased sharply overall and across many states. A multifaceted, collaborative public health and law enforcement approach is urgently needed. Response efforts include implementing the CDC Guideline for Prescribing Opioids for Chronic Pain (4), improving access to and use of prescription drug monitoring programs, enhancing naloxone distribution and other harm reduction approaches, increasing opioid use disorder treatment capacity, improving linkage into treatment, and supporting law enforcement strategies to reduce the illicit opioid supply. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|